SBL
TMO icon

Sargent Bickham Lagudis’s Thermo Fisher Scientific TMO Stock Holding History

Sargent Bickham Lagudis’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100
Closed -$67K – 1017
2021
Q4 		$67K Buy
+100
New +$62.4K 0.01% 405

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sargent Bickham Lagudis's TMO Position: Q4 2022 in Review

Sargent Bickham Lagudis increased its Thermo Fisher Scientific (TMO) stake by 1.8% in Q4 2022, buying an estimated $64.6K and bringing the position to 6,912 shares worth $3.81M. The position accounts for 0.31% of the portfolio, ranked #70.

Sargent Bickham Lagudis first reported a position in TMO in Q1 2016 and has held it in 28 quarters since. The position peaked at $4.48M in Q4 2021. 2,374 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

  • Sargent Bickham Lagudis held 6,912 shares of Thermo Fisher Scientific worth $3.81M as of Q4 2022.
  • Sargent Bickham Lagudis bought 122 Thermo Fisher Scientific shares in Q4 2022, an estimated $64.6K.
  • Thermo Fisher Scientific made up 0.31% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #70 holding.
  • Sargent Bickham Lagudis first reported a position in Thermo Fisher Scientific in Q1 2016 and has held it in 28 quarters since.
  • Sargent Bickham Lagudis's Thermo Fisher Scientific position peaked at $4.48M in Q4 2021.
  • 2,374 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.